{"version":"1.0","type":"link","title":"Neoadjuvant camrelizumab combined with metronomic chemotherapy in patients with advanced esophageal squamous cell carcinoma: a pilot randomized phase 2 trial.","author_name":"Chen Z 외","author_url":"https://prs-insight.online/author/Chen%20Z","provider_name":"PRSinsight","provider_url":"https://prs-insight.online","thumbnail_url":"https://prs-insight.online/og/paper/167840","thumbnail_width":1200,"thumbnail_height":630}